United Kingdom Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342806
  • Report
  • Region: United Kingdom, Great Britain
  • 260 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • Pfizer Inc
  • MORE
United Kingdom Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "United Kingdom Drug Delivery Devices Market Outlook to 2023", provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the United Kingdom Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Medtronic Plc
  • Pfizer Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, United Kingdom
3.1 Drug Delivery Devices Market, United Kingdom, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, United Kingdom, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, United Kingdom, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, United Kingdom, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, United Kingdom, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, United Kingdom, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, United Kingdom, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, United Kingdom, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, United Kingdom
4.1 Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2016
4.3 Central Venous Catheters Market, United Kingdom, Revenue ($m), 2009-2016
4.4 Central Venous Catheters Market, United Kingdom, Revenue ($m), 2016-2023
4.5 Central Venous Catheters Market, United Kingdom, Volume (Units), 2009-2016
4.6 Central Venous Catheters Market, United Kingdom, Volume (Units), 2016-2023
4.7 Central Venous Catheters Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
4.8 Central Venous Catheters Market, United Kingdom, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, United Kingdom
5.1 Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, United Kingdom, Segment Contribution (%), 2016
5.3 Infusion Systems Market, United Kingdom, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, United Kingdom, Revenue ($m), 2016-2023
5.5 Infusion Systems Market, United Kingdom, Volume (Units), 2009-2016
5.6 Infusion Systems Market, United Kingdom, Volume (Units), 2016-2023
5.7 Infusion Systems Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, United Kingdom, Company Share by Revenue ($m), 2016
6 Needle Free Injections Market, United Kingdom
6.1 Needle Free Injections Market, United Kingdom, Revenue ($m), 2009-2016
6.2 Needle Free Injections Market, United Kingdom, Revenue ($m), 2016-2023
6.3 Needle Free Injections Market, United Kingdom, Volume (Units), 2009-2016
6.4 Needle Free Injections Market, United Kingdom, Volume (Units), 2016-2023
6.5 Needle Free Injections Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
6.6 Needle Free Injections Market, United Kingdom, Company Share by Revenue ($m), 2016
7 Metered Dose Inhaler Devices Market, United Kingdom
7.1 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2009-2016
7.2 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2016-2023
7.3 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2009-2016
7.4 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2016-2023
7.5 Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
7.6 Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in United Kingdom, Drug Delivery Devices Market
8.1 B. Braun Melsungen AG
8.2 Teleflex Inc
8.3 GlaxoSmithKline Plc
8.4 Baxter International Inc
8.5 AstraZeneca Plc
8.6 Boehringer Ingelheim GmbH
8.7 Pfizer Inc
8.8 Becton Dickinson and Co
8.9 Smiths Medical
8.10 Merck & Co Inc
8.11 Fresenius Kabi AG
8.12 Medtronic Plc
8.13 Hospira Inc
8.14 Terumo Corp
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Acquisition
10.2 Asset Transactions
10.3 Debt Offerings
10.4 Equity Offerings
10.5 Partnerships
10.6 Venture Financing
11 Recent Developments
11.1 Corporate Communications
11.2 Financial Announcements
11.3 Legal And Regulatory
11.4 Other Significant Developments
11.5 Product News
11.6 Strategy And Business Planning
12 Appendix
12.1 Research Methodology
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, United Kingdom, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, United Kingdom, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Needle Free Injections Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 35: Needle Free Injections Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 36: Needle Free Injections Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Needle Free Injections Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 41: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 42: Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: SMC Acquires Oval Medical Technologies
Table 46: GW Pharma May Sell Itself
Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 48: Mylan Raises USD551.6 Million in Public Offering of Bonds Due 2020
Table 49: Nemaura Pharma to Raise up to USD6.2 Million in Equity Financing
Table 50: Midatech Pharma Raises USD19.8 Million in Private Placement of Shares
Table 51: Alimera Sciences Enters into Licensing Agreement with pSivida
Table 52: Bluegrass Vascular Enters into Partnership with Merit Medical
Table 53: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 54: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 55: Propeller Health Enters into Agreement with Novartis Pharma
Table 56: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology
Table 57: Pfizer Terminates its Licensing Agreement with pSivida
Table 58: Clinigen Group Enters into Distribution Agreement with BioQ Pharma
Table 59: BioQ Pharma Enters into Agreement with Galen
Table 60: ITL Biomedical Enters into Distribution Agreement with bioMerieux Canada
Table 61: Herantis Pharma Enters into Agreement with Renishaw
Table 62: Bespak Europe Enters into Development Agreement with Biopharmaceutical Company
Table 63: Bayer Enters into Licensing Agreement with DelSiTech
Table 64: BioCorRx Enters into Licensing Agreement with Therakine
Table 65: Glide Technologies Raises USD4 Million in Venture Financing
Table 66: Glide Pharma Raises USD4 Million in Venture Financing
Table 67: Orthoson Raises Funds in Series B Equity Financing
Table 68: OxSonics Raises Funds in Series B Equity Financing
Table 69: Medherant Raises USD2 Million in Venture Financing

List of Figures
Figure 1: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, United Kingdom, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, United Kingdom, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, United Kingdom, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, United Kingdom, Company Share (%) 2016
Figure 18: Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, United Kingdom, Company Share (%) 2016
Figure 33: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Needle Free Injections Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 36: Needle Free Injections Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 37: Needle Free Injections Market, United Kingdom, Company Share (%) 2016
Figure 38: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 41: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 42: Metered Dose Inhaler Devices Market, United Kingdom, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Teleflex Inc
  • GlaxoSmithKline Plc
  • Baxter International Inc
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Pfizer Inc
  • Becton Dickinson and Co
  • Smiths Medical
  • Merck & Co Inc
  • Fresenius Kabi AG
  • Medtronic Plc
  • Hospira Inc
  • Terumo Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll